Australian TGA Approves Illuccix® for Prostate Cancer Imaging

Go back to Australian TGA Approves Illuccix® for Prostate Cancer Imaging
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.88 +0.67 (6.56%)
Previous Close $10.21    52 Week High $2.18 
Open $10.81    52 Week Low $0.30 
Day High $11.07    P/E N/A 
Day Low $10.74    EPS $-3.32 
Volume 67,941